Coming together of universities aims to reduce morbidity and mortality associated with physical and serious mental illness in people
A Memorandum of Understanding (MoU) has been signed between Rawalpindi Medical University and University of York, UK to boost teaching, training, service delivery and research at different levels.
Professor Fareed Aslam Minhas, Member Syndicate and Co-Chairman of Board of Advanced Studies & Research at RMU informed that the collaboration will improve healthcare in the field of mental and physical multimorbidity.
MoU to focus on mentally-ill people
The proposed collaboration programme will focus on people suffering from mental illness in low and middle-income countries (LMICs). It will also target a major cause of global disease burden and health inequalities in South Asia.
Well, National Institute of Health Research (NIHR) Global Health Research Group on Improving Outcomes in Mental and Physical Multimorbidity and Developing Research Capacity (IMPACT) in South Asia at the University of York. It is a collaboration of academic, non-governmental and policy organisations in the UK, Bangladesh, India and Pakistan that have come together to develop research on mental and physical health comorbidity.
The ‘IMPACT in South Asia Group’ will generate new knowledge and build research capacity to evaluate and implement evidence-based interventions for mental and physical multimorbidity.
IMPACT in South Asia Group is led by the University of York and other partners include Hull School of Medicine, UK University of Leeds, UK University of Southampton, UK Kings College of London, UK The London School of Economics and Political Science, UK World health Organisation, Bangladesh National Institute of Mental Health-Neuro Science, India Institute of Psychiatry and Rawalpindi Medical University.
Moreover, the group’s long-term objectives aligned with global and country priorities for Bangladesh, India and Pakistan. It aims to reduce morbidity and mortality associated with physical and serious mental illness in people. It will also work to reduce depression or anxiety in people with chronic physical conditions.